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A number of bacteriophages have been identified that target the Vi capsular antigen of Salmonella enterica
serovar Typhi. Here we show that these Vi phages represent a remarkably diverse set of phages belonging to
three phage families, including Podoviridae and Myoviridae. Genome analysis facilitated the further classifi-
cation of these phages and highlighted aspects of their independent evolution. Significantly, a conserved
protein domain carrying an acetyl esterase was found to be associated with at least one tail fiber gene for all
Vi phages, and the presence of this domain was confirmed in representative phage particles by mass spectro-
metric analysis. Thus, we provide a simple explanation and paradigm of how a diverse group of phages target
a single key virulence antigen associated with this important human-restricted pathogen.
Bacteriophages are dependent for their survival on the pres-
ence of susceptible host bacteria in their environment. The first
stage of recognition of the bacterial host normally involves
binding of a specific phage attachment protein to a receptor
molecule on the bacterial surface. Bacteria can evade phage
infection by various mechanisms, including accumulating es-
cape mutations in the receptor, acquiring phage inhibitory
proteins, or directly modifying the receptor, for example, lipo-
polysaccharide (LPS) (43). In addition, phage can adapt to
recognize different receptors through a number of genetic
mechanisms involving evolution of their attachment proteins
(20) or by tropism switching (21, 22).
Phage can exploit capsular exopolysaccharides as receptors,
some of which are associated with virulence in pathogens (5,
23, 35). A notable example is the Vi capsule found in Salmo-
nella enterica serovar Typhi (S. Typhi) and some isolates of S.
Dublin and Citrobacter freundii (29). The Vi capsule of S. Typhi
is an important virulence factor, facilitating the bacteria to
escape opsonization and other forms of immune surveillance
(14, 30) as well as potentially helping the bacteria to evade
phage that would otherwise target the O:9 LPS, which the Vi
capsule can, at least in part, mask (27). In the middle of the last
century, a set of lytic phages were isolated that utilized the Vi
capsule as a receptor (6). These Vi phages were exploited in
diagnostic laboratories as a “typing set” to distinguish between
different strains of S. Typhi isolated from typhoid patients (8).
A secondary typing set was generated from Vi typing phage II
by adapting this phage to grow on different S. Typhi hosts (6).
At this time, typhoid was still common in many parts of Europe
and North America, and clinicians tested some of these Vi
phages for their potential in phage therapy experiments with
human typhoid patients (11). Although this work showed
significant promise, phage therapy gradually disappeared
from clinical practice in many countries as antibiotics be-
came readily available.
S. Typhi is a monophyletic serovar of the broad enteric
species S. enterica (16, 31). Interestingly, S. Typhi is host re-
stricted to humans and has no known zoonotic source. Unlike
many other S. enterica serovars, S. Typhi normally causes a
systemic infection and does not persist in the intestine effi-
ciently, where high levels of bacteriophage are present. Al-
though it is rare in developed countries, S. Typhi is still a
significant cause of mortality in many developing countries
(26). Most current clinical isolates are Vi positive when first
isolated (2), but it is noteworthy that the Vi capsule biosyn-
thesis and export genes are carried by an operon within a
potentially unstable island called Salmonella pathogenicity is-
land 7 (SPI-7) (29).
Although some phenotypic characterization of the Vi phage
has been undertaken (1), very little has been performed at the
molecular level. We previously showed that Vi typing phage
II-E1 is related to the S. Typhimurium phage ES18 (4, 28),
with synteny in many capsid and tail proteins. We have now
further characterized the other members of this S. Typhi Vi
phage collection, designated types I, III, IV, V, VI, and VII
(abbreviated from here on as Vi phages I, III, IV, etc.) (6, 11),
by utilizing electron microscopy and genomic analysis. This
analysis shows that this collection of Vi phages represents a
diverse group of bacteriophages that have adapted to growth
on S. Typhi through convergent evolution within their tail
spike protein genes and the acquisition of conserved acetyl
esterase domains.
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MATERIALS AND METHODS
Original sources of S. Typhi Vi bacteriophages, bacterial strains, and growth
conditions. Vi phages I, III, IV, V, VI, and VII were obtained from the Health
Protection Agency (HPA), Colindale, London, United Kingdom, but the original
sources of these phages date from the 1930s through 1955. Vi phages I to IV were
isolated from clinical samples of stools obtained from patients with typhoid fever
in Toronto, Canada (7–9), while Vi phages V and VI were originally isolated by
Desranleau in the state of Quebec, Canada (11), and Vi phage VII originated
from Germany in 1955 (3). Vi phage II-E1 was obtained from Stanford Univer-
sity (28).Vi phage I produces very small plaques of 0.02 cm on S. Typhi Ty2
lawns, and Vi phage II-E1 produces 0.15-cm plaques. Vi phage III plaques are
0.25 cm in diameter, while Vi phage IV plaques are more heterogeneous in size
and appearance. Vi phages V, VI, and VII all form larger 0.3- to 0.4-cm plaques,
with Vi phage VI plaques being consistently the largest and having strikingly
clear centers. In contrast, phage V and VII plaques have turbid centers.
The requirement of S. Typhi Vi phages III, IV, V, VI, and VII to target the Vi
capsule for infection was confirmed using S. Typhi strain BA256, in which the
tviB gene of the S. Typhi viaB operon (29) had been knocked out by insertion of
a kanamycin cassette. None of these phages were able to infect under these
conditions.
For propagation of all phage, S. Typhi BRD948 was used as the host. This
strain not only is heavily capsulated but also is attenuated and can be used in a
containment level 2 environment (38). S. Typhi BRD948 contains deletions in
two genes of the aromatic pathway (aroC and aroD) and an additional deletion
within the gene for the heat shock protein HtrA (38). All S. Typhi isolates were
grown in Luria broth or agar plates at 37°C supplemented with aromatic amino
acids as described previously (28). Phage lysates were made as described previ-
ously and used 0.35% agar in the top layer and 1.2% agar in the base (33).
Preparation of phage stocks and CsCl-purified DNA and restriction enzyme
analysis of phage DNA. Purified phage DNA was obtained via treatment of
CsCl-purified phage particles. These were purified using standard procedures
described previously (28) and summarized below.
One liter of phage lysate was obtained by infecting S. Typhi BRD948 at
multiplicities of infection ranging from 0.1 to 10 with the various S. Typhi Vi
phage isolates at 37°C. It typically took 7 h to generate high-titer stocks. After
being centrifugally spinned to remove cellular debris, RNase A and DNase were
added to eliminate bacterial nucleases. The phage particles were concentrated by
addition of NaCl (to a final concentration of 1%) and polyethylene glycol 8000
(PEG8000) (10%, wt/vol). After overnight incubation at 4°C to precipitate the
phage particles from the solution, they were spun down at 11,000  g for 30 min,
and the phage pellet was resuspended in 16 ml of lambda diluent. An equal
volume of chloroform was added to remove any remaining cell debris and PEG
and spun once more for 15 min at 11,000  g. Finally, the phage pellet was
resuspended in lambda diluent and purified by two-stage CsCl buoyant-density
ultracentrifugation. DNA was obtained from the purified phage particles by
proteinase K and phenol-chloroform treatments.
Vi phage restriction enzyme analysis. Preliminary analysis and comparison of
the various Vi phage DNA preparations were carried out by restriction analysis
in order to confirm the quality of the DNA and any degree of relatedness
between the phages. Restriction enzymes were purchased from Roche UK and
used as recommended by the manufacturer.
DNA sequencing and annotation. A combination of Sanger sequencing meth-
ods and 454 Illumina sequencing technologies was used to sequence all the
phages to ensure complete coverage. PCR and primer walking was used to fill
any gaps with low coverage. Artemis (32) was used to facilitate annotation of the
Vi phage genomes. Pairwise whole-genome comparisons of Vi phage with the
related phages T7 (GenBank accession number V01146), K1E (GenBank acces-
sion number AM084415), K1F (GenBank accession number AM084414), and
SP6 (GenBank accession number AY370673) were performed using tBLASTx
and visualized using the Artemis Comparison Tool (ACT) (36). Circular dia-
grams were made using DNAPlotter (37), and genome comparison figures were
produced using easyFig (M. Sullivan, unpublished data).
Comparisons of the maturation-adhesion genes were carried out using the
ClustalW package found within MacVector 7.2 DNA analysis software (Invitro-
gen). Pfam was used to identify significant domains (http://pfam.sanger.ac.uk
/search), and to identify conserved structures in selected proteins, we used the
tool Phyre (protein homology/analogy recognition engine search) (http://www
.sbg.bio.ic.ac.uk/phyre/html/). The latter program combines primary and second-
ary structure profile information using optimized profile-profile comparison al-
gorithms and can predict domain functions that may be missed by Pfam.
Electron microscopy studies of the Vi phage. CsCl-purified phage particles for
electron microscopy (EM) analysis were dialyzed against three changes of
lambda diluent to remove the heavy metal from the sample. The phage particle
suspension was mixed with fresh 0.1 M ammonium acetate buffer diluted until
just slightly turbid. A total of 5 l of suspension was applied for 30 s to freshly
glow-discharged carbon/Formvar-coated 200-mesh copper grids. Finally, 5 l of
5% aqueous ammonium molybdate with 1% trehalose was added for a few
seconds and then removed with filter paper. The grid was air dried for 30 min and
then imaged on a 120-kV Philips Tecnai Spirit BioTwin transmission electron
microscopewith a Tietz F415 charge-coupled-device (CCD) TemCam camera at
magnifications ranging from 10,000 to 60,000.
Mass spectrometry. Mass spectrometric analysis of the structural proteins was
performed similarly as previously described (28), with some modifications. As
previously described, CsCl-purified phage particles were used for this study after
extensive dialysis against lambda diluent to remove CsCl and other impurities
from the preparations. Polypeptide bands were excised, destained completely in
50% methanol-50% ammonium bicarbonate at 50 mM, and digested with trypsin
(sequencing grade; Roche) overnight. Peptides were then extracted with 0.5%
formic acid-50% methanol, dried, and resuspended in 0.5% formic acid prior to
mass spectrometric analysis.
The mass spectrometric analysis was performed with a Finnigan LTQ FT Ultra
mass spectrometer (Thermo Electron), controlled by Xcalibur 2.0 SR2, and
coupled with an UltiMate 3000 capillary/nano-high-performance liquid chroma-
tography (HPLC) system (Dionex). Samples were desalted on a trap (PepMap
C18, 300 m [inside diameter] by 5 mm; Dionex) and then separated on a bridged
ethyl hybrid (BEH) C18 column (75 m [inside diameter] by 100 mm; Waters)
with a gradient of 4 to 32% acetonitrile-0.1% formic acid in 45 or 60 min. LTQ
FT Ultra was operated in standard data-dependent acquisition mode, with a
Fourier transform ion cyclotron resonance (FT-ICR) resolution of 100,000 at m/z
400 and a survey scan within m/z 400 to 1,500. The four most abundant multiply
charged ions were subject to tandem mass spectrometry in the LTQ ion trap at
an isolation width of 2 D, a dynamic exclusion width of 20 ppm, and a duration
of 90 s. Peak lists were generated by using BioWorks 3.3 (Thermo Electron). The
data were subjected to a database search with Mascot Server 2.2 (Matrix Science)
against an in-house-built phage-translated genomic database using the following
parameters: trypsin/P with a maximum of 3 missed cleavages sites, peptide mass
tolerance at 20 ppm, tandem mass spectrometry fragment mass tolerance
at 0.5 Da, and variable modifications for acetyl (N-term), carbamidomethyl
(C), deamidated (NQ), dioxidation (M), formyl (N-term), Gln3pyro-Glu (N-
term Q), Glu3pyro-Glu (N-term E), methyl (E), and oxidation (M). The
matched peptides were manually validated.
Nucleotide sequence accession numbers. The complete genome annotation for
Vi phages I and VI can be found in GenBank or EMBL with accession numbers
FQ312032 and FR667955, respectively. Full annotation details and comprehen-
sive homology scores for all the Vi phages can be found at the following website:
ftp://ftp.sanger.ac.uk/pub/pathogens/Phage/. Visualization of the EMBL FTP
files with ARTEMIS is a suggested option (http://www.sanger.ac.uk/resources
/software/artemis/).
RESULTS
Morphology of the Vi phage. Table 1 provides a general
overview of the seven Vi phages that constitute this collection.
We have previously shown that Vi phage II is a member of the
Siphoviridae, related to S. Typhimurium phage ES18 (28). In
order to refine the classification of the remaining different Vi
TABLE 1. General characteristics of S. Typhi phages I to VIIa
Vi phage Morphology Genome size(bp) GC ratio (%)
No. of CDSs
(no. of
introns)
I Myoviridae 157,061 45.37 210 (0)
II Siphoviridae 45,051 47.03 52 (0)
III Podoviridae 38,969 50.75 60 (1)
IV Podoviridae 44,618 47.12 62 (0)
V Podoviridae 38,582 48.98 52 (1)
VI Podoviridae 38,367 49.47 51 (1)
VII Podoviridae 39,248 49.57 54 (1)
a This data summarizes the basic information collected for all seven Vi phages,
including genome size and number of predicted proteins.
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typing phages, we exploited a combined approach involving
electron microscopy and DNA sequencing. Initially, each of
the different phages was examined under the electron micro-
scope following negative staining of purified phage prepara-
tions. This microscopy data allowed the assignment of the
phage to Myoviridae morphotype A1 (Vi phage I) and the
Podoviridae (Vi phages III, IV, V, VI, and VII). This is in good
agreement with a previous study by Ackermann et al. (1) (Fig.
1). Myoviridae Vi phage I shows a very complex overall tail
fiber structure reminiscent of a number of recently described
phages, and in particular, Salmonella phage Det7 (41). Figure
1a shows that Vi phage I possesses an isometric icosahedron-
shaped head, with a dimension of 88 nm from apex to tail
joint and 90-nm width. The tail shows clear evidence of a
collar, followed by the major tail structure at 115 nm in
length and at 18 nm in diameter. The smaller inset image
shown in Fig. 1a most likely shows the phage after tail con-
traction. Each corner of the icosahedron-shaped head has a
visible small extension (Fig. 1a). An end plate is present, ter-
minating the tail, with a further intricate array of minor tail
fibers observable following loss of the capsid (Fig. 1b). These
fine tail fibers can be seen as having a four-pronged arrange-
ment, with a further fine fiber attaching this structure to the
array surrounding the phage tail base. These unfolded and
ramified branched tail fiber structures are very similar to those
reported for S. Heidelberg phage 10 (10).
The other Vi phages examined, III to VII, are all morpho-
logically members of the Podoviridae (Fig. 1c), which repre-
sents an extensive family of bacteriophages, with T7 and SP6
among the best studied examples (12, 36). These Vi phages
each have an icosahedral capsid with a diameter of 60 nm.
All these Vi Podoviridae phages possess short tails and an
associated electron-dense structure that extends into the cap-
sid. The tail structure is observed separated from the capsid in
Fig. 1c. This central tail-portal structure is frequently very well
stained. Based upon the arrangement previously described in
structural studies of T7 and K1E phage (20), the arrangement
of six minor fine tail fibers seen in the electron micrograph for
Vi phage VI (Fig. 1c) is likely to possess the tail spike protein
required for receptor recognition.
Comparative sequence analysis of Vi phages I, III, IV, V, VI,
and VII. DNA was prepared from each of the different typing
phages, and the DNA sequence was determined for each one,
as described in Materials and Methods. Annotation and anal-
ysis of each of the Vi phage genomes revealed significant
information about the genetic and evolutionary relationships
between each of the phages. Analysis of the intron and intein
contents of each Vi phage can be found in the supplemental
material.
The genome of Vi phage I, shown in Fig. 2, closely resembles
that of the large lytic phage of Shigella boydii, phiSboM-AG3
(GenBank accession number NC_013693), displaying remark-
able synteny along its entire length. The 157-kbp genome is
circular, and it encodes an estimated 209 proteins, of which 170
have homology within this Shigella phage. Seventy-two of these
predicted proteins are presently unique to Vi phage I and
phiSboM-AG3 only. Twenty-one predicted proteins are hypo-
thetical, with no similarities to any proteins presently found in
the databases. A cluster of genes carried by Vi phage I encod-
ing capsid, DNA packaging, and neck proteins (Vi01_152c to
FIG. 1. (a) Electron micrograph images of S. Typhi Vi phage I.
Note the fine tail structure and the presence of a collar and tail end
plate. The minor tail fibers surround the bottom of the major phage
tail. The contracted tail sheath exposes a long linear structure that
extends beyond the collar. (b) Electron micrograph image of the Vi
phage I tail. It is possible in these photographs to see the intricate
detail of the minor tail fibers—the tail spikes. These surround the
major tail fiber in a chandelier-like fashion. They have at least 4
prongs, plus a fifth prong that is attached to the region surrounding the
bottom of the major tail fiber (see magnified insert of this structure,
which was seen separated from the tail in various electron micrograph
images of this phage). These ramified branched structures represent an
unfolding of the original closely packed tail fibers shown in panel a. (c)
Vi bacteriophages III, IV, and VI. Types V and VII are not shown, but
they have morphology similar to that of type IV. All these phages can
be characterized as possessing short stumpy tail structures. In a num-
ber of these phage images, the tail structure seems to extend into the
main body of the capsid in a manner similar to that seen in a number
of Podoviridae phages.
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Vi01_166c) are also found as a gene cluster with variable
homology within a variety of cyanobacterial lytic phages, such
as Prochlorococcus phage P-SSM2 and Synechococcus phage
S-PM2. A significant number of genes with known prototypes
carried by the T4 phage were identified during the annotation
(25, 44), and these were added to GenBank (see Materials and
Methods). Significantly, the number and type of T4 prototypes
found in the Vi phage I genome closely matched those iden-
tified in Synechococcus phage S-PM2 (24).
Sequence analysis of Vi phage III shows that it closely re-
sembles enterobacterial phage K1F, while Vi phages V, VI,
and VII most closely resemble the T7 phage (Fig. 3). The
genomes of Vi phage V, VI, and VII were very similar to each
other, as Fig. 3 illustrates. At the DNA level, homology ex-
ceeded 95% with respect to Vi phages VI and VII and 90% for
Vi phage V with respect to VI and VII. Synteny is well con-
served throughout these four genomes, and most gene prod-
ucts have very high similarity scores in excess of 90% at the
amino acid level, with the exception of Vi phage III. Vi
phage III also has marked similarity to a number of other
lytic phages, particularly the enterobacterial phages EcoDS1
and T7.
Vi phage IV most clearly resembles the S. Typhimurium lytic
phage SP6 (36). The coding sequence (CDS) synteny and iden-
tity again are consistently high throughout the genome, with
only a small number of genes not found in SP6, K1-5, or K1E
(Fig. 3) (20). This includes a putative gene for S-adenosylme-
thionine hydrolase, which is not present in any of these three
phages. At the DNA level, there are particular regions of Vi
phage IV that are 80% identical to SP6, while in other
regions, there is little or no DNA identity.
Using this DNA sequence data, we were able to classify Vi
phages III, V, VI, and VII as belonging to the Autographiviri-
nae subfamily, T7-like genus (19). Vi phage IV has emerged
from a different phage lineage from III, V, VI, and VII (13). Vi
phage III is significantly more distant from Vi phages V, VI,
and VII (Fig. 3).
The tail spike proteins of Vi phages I to VII harbor con-
served acetyl esterase domains. All seven Vi phages encode a
maturation-adhesion tail spike protein that recognizes the Vi
FIG. 2. Genomic map of Vi phage I. Genes with predicted functions are shown alongside a key to the gene colors used.
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exopolysaccharide capsule as the receptor. Additionally, Vi
phage I harbors two further candidate tail spike proteins, and
Vi phage IV harbors one extra tail spike. This is summarized in
Fig. 4. A comprehensive analysis of the maturation-adhesion
tail spike receptor binding proteins was performed using Clust-
alW (see Table S2 in the supplemental material) in combina-
tion with the Pfam and Phyre programs. The latter two pro-
grams search for known protein domains and secondary
structures, respectively. Using these approaches, we were able
to define clear domains shared within the tail spikes for all Vi
phages (Fig. 3). With the exception of Vi phage IV, the
Podoviridae Vi phages examined all harbored N-terminal do-
mains with homology to known tail spike proteins that likely
carry the region involved in phage tail attachment to the cap-
sid. For example, the first 160 amino acids of the tail spike
proteins of Vi phages V, VI, and VII are most similar to those
of the corresponding tail spike protein of the T7 phage, which
is Gp17, or in phage K1F, Gp36.
Unlike the tail spike protein of the other Vi Podoviridae
phage examined, the candidate Vi phage IV tail spike protein
does not show any homology at the N terminus to any known
phage adaptor gene which is required for tail spike attachment
to the capsid. Significantly Vi phage IV and other closely re-
lated phages, including SP6, K1E, and K1-5, have been shown
to be attached to the phage particle by a different mechanism,
a trimeric adaptor protein designated gene product gp37 (20).
A candidate gene, Vi04_45, was identified in the Vi phage IV
genome, which is over 90% identical to the trimeric adaptor
protein gp37 of SP6 phage. As with SP6, a further gene en-
coding a probable tail spike protein is present in phage IV (12),
and this is designated Vi04_59 and highlighted in Fig. 4. This
gene has significant similarity to a probable tail fiber gene of Vi
phage I, Vi01_0173c, which is adjacent to the three tail spike
genes of this phage.
The receptor for all Vi phages has been postulated to in-
clude the acetyl groups that decorate the Vi exopolysaccharide
capsule, which is a polymer of -1,4-linked N-acetyl galac-
tosaminuronate. Significantly, a further domain with significant
homology to acetyl esterases was identified by BLASTP and
Pfam data in all seven maturation-adhesion tail spikes proteins
of the Vi phage (Fig. 3 and 4; see also Table S2 in the supple-
mental material). This conserved domain is likely involved
directly in deacetylation of the Vi exopolysaccharide and is
annotated as a putative acetyl esterase based upon Pfam iden-
tification and Phyre analysis. The acetyl esterase of Vi phages
V, VI, and VII can be grouped together in particular due to
FIG. 3. Comparison of the genomes of Vi phage III, IV, V, VI, and VII with those of T7 and SP6. Comparison of the genomes of the S. Typhi
Vi phage types III, IV, V, VI, and VII, shown aligned with the genomes of the related phages SP6 (GenBank accession number AY370673) and
T7 (GenBank accession number V01146). Regions with significant amino acid similarity between the genomes are linked by shading (percentage
identity [tBLASTx] indicated on the right). The phage genes identified are color coded according to their predicted function (see key). The scale
bar indicates genome length. Vi phages V, VI, and VII are highly related to phage T7. Vi phage III is more distant from T7 and is in fact more
similar to a T7-like phage, K1F (data not shown). Vi phage IV is even more distant from the T7 genus and is most similar to K1E (data not shown)
and SP6. In spite of the differences between the genomes of these five Vi phages, their tail spike proteins are highly conserved but unrelated to
the tail spike proteins carried by SP6 and T7.
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their very high similarity, as shown in the ClustalW alignment
provided in Table S2 and a dot matrix comparison (see Fig. S5
in the supplemental material). A putative adhesion region was
identified downstream of the acetyl esterase domain in all
seven phages by BLASTP analysis, showing some homology to
motifs such as that of yadA (15). This was further confirmed by
Phyre analysis (data not shown).
Mass Spectrometric analysis of S. Typhi Vi phages I and VI.
Mass spectrometric analysis was performed on purified prep-
arations of Vi phages I and VI in order to further characterize
the phages and their tail spike proteins. Vi phage I contains a
number of features that make this a phage of particular special
interest. The annotated sequence indicated the presence of
three tail spikes, including Vi01_171c associated with recogni-
tion of the acetyl modification on the Vi exopolysaccharide.
The intricate tail fiber structure visible in electron micros-
copy indicated that we might anticipate multiple distinct tail
spikes on Vi phage I. The mass spectrometric data, summa-
rized in Table 2, identified 41 proteins, of which 18 are likely to
be involved with tail morphogenesis. Other proteins identified
included a number of those associated with the capsid. Signif-
icantly, the three candidate tail spike proteins designated
Vi01_170c, Vi01_171c, and Vi01_172c were also present in this
data set. Vi01_171c is the tail spike protein that recognizes the
acetyl modification on the Vi capsule. Eighteen genes previ-
ously identified in annotation as putative or hypothetical phage
proteins were positively identified in the mass spectrometric
analysis, and these have therefore been renamed as phage-
associated proteins in Table 2. Eight of these are unique to Vi
phage I and phiSboM-AG3.
The mass spectrometric data for purified Vi phage VI, which
belongs to the same genus as the T7 phage, are summarized in
Table 3. Constituents of the tail were identified (part of gp17
of T7), as were the head-to-tail joining protein (gp8) and a
variety of internal virion proteins equivalent to gp14, gp15, and
gp16 of T7. We also confirmed the presence of the predicted
capsid assembly protein Vi06_34 and the major capsid protein
Vi06_35. The tail spike that recognizes the Vi exopolysaccha-
ride, Vi06_43, was also positively identified in the mass spec-
trometric analysis.
DISCUSSION
In this paper, we have described the morphology and ge-
nome structure of the classic S. Typhi Vi phage set. This phage
collection dates from the early 1930s for Vi phages I to IV (8),
1948 for Vi phages V and VI (11), and 1955 for Vi phage VII
(3). The present study was undertaken to definitively classify
the phages and to understand how all these phages had be-
come adapted to recognize the Vi capsular antigen as a recep-
tor. Morphologically, these phages are diverse and belong to
three phage families, the Myoviridae (Vi phage I), the Sipho-
viridae (Vi phage II) (28), and the Podoviridae (Vi phages III to
VII). The combined data indicate that phages belonging to
distinct genus and related to classical phages such as T7 and
SP6 have retained their normal gene complement but have
exchanged, via recombination, their tail spikes to target the Vi
capsule. The preponderance of the T7 and SP6 genera shows
that these phage classes allowed diverse genetic exchanges to
occur while retaining fitness. Though Vi phages III, IV, V, VI,
FIG. 4. Tail spike proteins of all the sequenced Vi phage I to VII. Using a combination of BLASTP and Pfam searches, we identified all the
likely tail spike proteins of the classic Vi phage set and the likely target receptor. At least one tail spike protein was identified in all of the Vi phages.
Significantly, at least one tail spike protein in all had a Pfam domain for an acetyl esterase. A number of phages in the Vi phage set also encoded
other tail spikes, but their targets are unknown. aa, amino acids.
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and VII are all Podoviridae members, sequencing revealed that
Vi phages V, VI, and VII are highly related and form a dis-
tinctive clade with extensive synteny to T7 phage, whereas Vi
phage III is slightly more distant but has significant homology
to another member of the T7-like phage genus, K1F. Vi phage
IV displays significant synteny to Salmonella phage SP6. We
found that Vi phage I is remarkably similar to the recently
database-submitted phage phiSboM-AG3 that infects S. boydii
(GenBank accession number NC_013693). Vi phage II has
been previously shown to share regions of synteny with the
lysogenic phage ES18.
Although the Vi phages are genetically and morphologically
diverse, they all share a domain linked to the tail spike that is
required for recognition and deacetylation of the Vi exopo-
lysaccharide (17, 18, 37). Unlike the endosialidases of bacte-
riophage that degrade the backbones of Escherichia coli K1 or
K5 capsular polysaccharides (20, 36), the acetyl esterases of the
seven Vi phages specifically target the acetyl modification on
the sugars themselves (17, 39, 40). It is possible that there are
phages with the capability to target and degrade the sugar
backbone of the Vi capsule in a way similar to that of the K1
phage, but these have not been identified to date. However,
this deacetylation enzyme may itself destabilize the long linear
Vi fibers due to loss of hydrogen bond cohesion (42). Thus,
targeting of the acetyl modification represents a simple but
efficient mechanism that allows these phages to infect S. Typhi.
Vi phage I encodes three tail spike proteins identified in both
the annotation and the mass spectrometric studies. Two of
these proteins share significant homology to the N-terminal
regions of the well-characterized tail spike protein of Salmo-
nella phage Det7 (41) and to orf00207 of S. boydii phage
phiSboM-AG3. The third tail spike protein encodes acetyl
esterase and shares significant homology in the first 161 amino
acids with orf00210, one of the tail spike proteins from phage
TABLE 2. Mass spectrometry analysis of Vi phage I
Gene designationa Description Mol wt
No. of peptide
sequences
identified per
protein
Vi01_006 Putative tail protein product 5503:6312 27,801 13
Vi01_034 T4-like baseplate tail tube cap 20271:21239 36,118 8
Vi01_035 Gp53 baseplate wedge subunit 21252:21806 21,534 8
Vi01_036 Conserved phage associated protein 21806:23194 52,590 16
Vi01_037 Phage-associated protein 23205:25145 70,019 22
Vi01_065c Gp2 DNA end protector protein 41170:41874 rev 28,329 11
Vi01_066 Baseplate tail tube initiator 41929:42873 35,020 5
Vi01_076 Baseplate hub subunit 48036:49661 59,079 7
Vi01_077 Gp25 baseplate wedge protein 49726:50106 14,119 7
Vi01_081c Glutaredoxin 51249:51476 rev 8,472 1
Vi01_092c Conserved phage-associated protein 60113:60466 rev 13,026 3
Vi01_093c Phage-associated protein 60527:61099 rev 20,383 7
Vi01_094c Phage-associated protein 61147:63546 rev 87,994 108
Vi01_096c Phage-associated protein 64004:64642 rev 22,864 4
Vi01_105 Conserved phage-associated protein 71048:71815 28,321 15
Vi01_112c Phage-associated protein 75633:75920 rev 10,868 1
Vi01_117c Phage-associated protein 78753:79199 rev 17,304 15
Vi01_140c Tail completion and sheath stabilizer protein 95723:96217 rev 18,533 2
Vi01_142c Conserved phage-associated protein 96906:97631 rev 25,368 3
Vi01_149c Phage-associated protein 99867:100310 rev 16,901 2
Vi01_152c Major capsid protein 100868:102190 rev 47,971 36
Vi01_154c Gp21 prohead protease 103168:103836 rev 24,454 10
Vi01_155c Conserved phage-associated protein 103847:104161 rev 12,349 5
Vi01_157c Gp20 portal vertex protein of the head 104382:106064 rev 63,067 48
Vi01_158c Gp19 tail tube protein 106135:106665 rev 19,900 10
Vi01_160c Gp18 tail sheath protein 107211:109106 rev 68,380 32
Vi01_163c Gp15 proximal tail sheath stabilization 112033:112731 rev 26,876 2
Vi01_164c Gp14 neck protein 112734:113375 rev 24,743 6
Vi01_166c Gp13 neck protein 113678:114430 rev 29,000 11
Vi01_169c Conserved phage-associated protein 115043:119881 rev 177,452 87
Vi01_170c Tail spike protein 119976:121766 rev 64,411 25
Vi01_171c Maturation-adhesion tail spike protein 121816:124014 rev 79,294 31
Vi01_172c Tail spike protein 124070:126610 rev 91,415 26
Vi01_173c Hemolysin-type calcium-binding protein 126661:129834 rev 111,484 41
Vi01_174c Putative tail fiber protein 129881:131071 rev 42,525 35
Vi01_175c Conserved phage-associated protein 131074:131928 rev 33,009 7
Vi01_176c Gp6 baseplate wedge subunit 131912:133693 rev 65,582 35
Vi01_179 Phage-associated protein (Vi phage I only) 138943:139176 8,054 3
Vi01_180 Conserved phage-associated protein 139186:139701 18,551 4
Vi01_183 Phage-associated protein (Vi phage I only) 141852:142301 16,820 7
Vi01_184 Phage-associated protein 142337:142792 17,332 1
a A significant number of CDSs were identified during this analysis, including those for many hypothetical proteins and a full range of structural proteins. These
included the major capsid, collar, baseplate, and all three predicted tail spike proteins.
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phiSboM-AG3. Vi phage IV contains one additional tail spike,
and this is similar in arrangement to other members of this
SP6-like genus of the Autographivirinae, which tend to recog-
nize two receptors, e.g., phage K1-5, which can recognize E.
coli capsular antigens K1 and K5 (34, 41).
While the mechanism by which phages exchange their re-
ceptor-recognition tail spikes via homologous recombination is
relatively well documented (20), the conditions within the bac-
terial host that permit these exchanges remain vague but are
beginning to be explored (34). Phages possessing multiple tail
spikes, such as those reported here, may offer a distinct advan-
tage in a mixed-phage infection by enhancing these possible
recombination exchanges, as they will carry not only the re-
ceptor used to infect the host bacteria but also other “surplus”
receptor-recognition cassettes as well. Thus, such an arrange-
ment would permit a large member of the Myoviridae, such as
Vi phage I, to coinfect a Vi-negative bacterial host along with
a Podoviridae member, theoretically yielding progeny for the
latter that may now carry the receptor for the Vi capsule.
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